Weight loss with glucagon‐like peptide‐1 receptor agonists in Bardet‐Biedl syndrome

Bardet–Biedl syndrome (BBS) is a rare genetic condition, characterized by ciliary protein dysfunction, leading to multi‐organ damage. People with BBS can develop early‐onset severe obesity and associated problems including the metabolic syndrome, type 2 diabetes and coronary heart disease. Weight ma...

Descripción completa

Detalles Bibliográficos
Autores principales: Ganawa, Shawg, Santhosh, Smrithi Hema, Parry, Lucy, Syed, Akheel A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9539684/
https://www.ncbi.nlm.nih.gov/pubmed/35932204
http://dx.doi.org/10.1111/cob.12546
_version_ 1784803543608197120
author Ganawa, Shawg
Santhosh, Smrithi Hema
Parry, Lucy
Syed, Akheel A.
author_facet Ganawa, Shawg
Santhosh, Smrithi Hema
Parry, Lucy
Syed, Akheel A.
author_sort Ganawa, Shawg
collection PubMed
description Bardet–Biedl syndrome (BBS) is a rare genetic condition, characterized by ciliary protein dysfunction, leading to multi‐organ damage. People with BBS can develop early‐onset severe obesity and associated problems including the metabolic syndrome, type 2 diabetes and coronary heart disease. Weight management can be challenging with the lack of effective medical therapies so far. We report a patient with BBS who underwent successful weight reduction through the use of glucagon‐like peptide‐1 receptor agonists.
format Online
Article
Text
id pubmed-9539684
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Blackwell Publishing Ltd
record_format MEDLINE/PubMed
spelling pubmed-95396842022-10-14 Weight loss with glucagon‐like peptide‐1 receptor agonists in Bardet‐Biedl syndrome Ganawa, Shawg Santhosh, Smrithi Hema Parry, Lucy Syed, Akheel A. Clin Obes Case Report Bardet–Biedl syndrome (BBS) is a rare genetic condition, characterized by ciliary protein dysfunction, leading to multi‐organ damage. People with BBS can develop early‐onset severe obesity and associated problems including the metabolic syndrome, type 2 diabetes and coronary heart disease. Weight management can be challenging with the lack of effective medical therapies so far. We report a patient with BBS who underwent successful weight reduction through the use of glucagon‐like peptide‐1 receptor agonists. Blackwell Publishing Ltd 2022-08-06 2022-10 /pmc/articles/PMC9539684/ /pubmed/35932204 http://dx.doi.org/10.1111/cob.12546 Text en © 2022 The Authors. Clinical Obesity published by John Wiley & Sons Ltd on behalf of World Obesity Federation. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Case Report
Ganawa, Shawg
Santhosh, Smrithi Hema
Parry, Lucy
Syed, Akheel A.
Weight loss with glucagon‐like peptide‐1 receptor agonists in Bardet‐Biedl syndrome
title Weight loss with glucagon‐like peptide‐1 receptor agonists in Bardet‐Biedl syndrome
title_full Weight loss with glucagon‐like peptide‐1 receptor agonists in Bardet‐Biedl syndrome
title_fullStr Weight loss with glucagon‐like peptide‐1 receptor agonists in Bardet‐Biedl syndrome
title_full_unstemmed Weight loss with glucagon‐like peptide‐1 receptor agonists in Bardet‐Biedl syndrome
title_short Weight loss with glucagon‐like peptide‐1 receptor agonists in Bardet‐Biedl syndrome
title_sort weight loss with glucagon‐like peptide‐1 receptor agonists in bardet‐biedl syndrome
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9539684/
https://www.ncbi.nlm.nih.gov/pubmed/35932204
http://dx.doi.org/10.1111/cob.12546
work_keys_str_mv AT ganawashawg weightlosswithglucagonlikepeptide1receptoragonistsinbardetbiedlsyndrome
AT santhoshsmrithihema weightlosswithglucagonlikepeptide1receptoragonistsinbardetbiedlsyndrome
AT parrylucy weightlosswithglucagonlikepeptide1receptoragonistsinbardetbiedlsyndrome
AT syedakheela weightlosswithglucagonlikepeptide1receptoragonistsinbardetbiedlsyndrome

Ejemplares similares